The effect of the COVID-19 pandemic on young children's biological ageing

Jessica F Sperber Knott1, Melissa Miller2, Ariel Bellatin2

  • 1Max Planck Research Group Biosocial-Biology, Social Disparities, and Development, Max Planck Institute for Human Development, Berlin, Germany.

Child Development
|March 24, 2026
PubMed

Insights

The COVID-19 pandemic had no significant impact on biological aging in early childhood. This study found no evidence of large effects of pandemic exposure on epigenetic aging trajectories in infants up to 30 months old.

Area of Science:

  • Pediatrics
  • Developmental Biology
  • Epidemiology

Background:

  • The COVID-19 pandemic presented an unprecedented global health crisis.
  • Early childhood is a critical period for development, potentially sensitive to environmental stressors.
  • Biological aging, assessed via epigenetic clocks, offers a molecular measure of health and development.

Purpose of the Study:

  • To investigate the impact of exogenous COVID-19 pandemic exposure on biological aging in early childhood.
  • To examine epigenetic aging trajectories in infants experiencing varying durations of pandemic exposure.

Main Methods:

  • Longitudinal study recruiting pregnant women in New York City in 2019.
  • Saliva samples collected from infants at 1 month and children at 30 months postpartum.
  • Epigenetic age assessed using saliva samples to determine biological aging trajectories.

Main Results:

  • Infants experienced varying exposure durations to the pandemic in their first year of life (0-9.5 months at pandemic onset).
  • Analysis revealed no substantial evidence of large effects of pandemic exposure on biological aging trajectories between 1 and 30 months of age.

Conclusions:

  • Early childhood exposure to the COVID-19 pandemic did not appear to significantly alter biological aging trajectories.
  • Further research may explore long-term effects or specific subpopulations.

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.1K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
983
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
328
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
315
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
17